Market Cap 42.36M
Revenue (ttm) 190,000.00
Net Income (ttm) -74.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39,010.53%
Debt to Equity Ratio 0.00
Volume 1,425,300
Avg Vol 963,266
Day's Range N/A - N/A
Shares Out 98.09M
Stochastic %K 7%
Beta 0.53
Analysts Sell
Price Target $2.75

Company Profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 731 8389
Fax: 858 731 8394
Address:
10240 Sorrento Valley Road, Suite 300, San Diego, United States
akshgaikwad
akshgaikwad Sep. 11 at 9:11 PM
$ATYR dont they have to reverse split?? Stock is below $1.X for long time
0 · Reply
saneguy
saneguy Sep. 11 at 2:51 PM
$ATYR slow death march to the 30s before October’s stock split
0 · Reply
tedypa
tedypa Sep. 10 at 5:30 AM
0 · Reply
J__KARDOSS
J__KARDOSS Sep. 10 at 5:26 AM
0 · Reply
J__KARDOSS
J__KARDOSS Sep. 10 at 5:21 AM
0 · Reply
SpartanTrader117
SpartanTrader117 Sep. 10 at 12:20 AM
$ATYR easy short play
0 · Reply
MollyJones567
MollyJones567 Sep. 6 at 9:19 PM
$ATYR watching how the pipeline updates translate into the next earnings print. Market's been choppy but the focus stays on data readouts and cash runway commentary. Curious if guidance shifts at all this round. No rush, just observing how the story develops.
1 · Reply
Merlintrader
Merlintrader Sep. 2 at 10:22 AM
aTyr Pharma ($ATYR) Stock Hub 2026: What Does The FDA Protocol Response Change For The Efzofitimod Rebuild? https://www.merlintrader.com/atyr-pharma-stock-hub/
0 · Reply
STACKD0E
STACKD0E Sep. 1 at 10:44 PM
$ATYR $TLX 👁
0 · Reply
focafoca99
focafoca99 Sep. 1 at 9:05 PM
$ATYR provided an update on the expected FDA response timing for its Phase 3 efzofitimod pulmonary sarcoidosis study, now due mid-Sept 2026.
2 · Reply
Latest News on ATYR
aTyr Pharma Proxy statement: Proxy filing

Sep 11, 2026, 8:00 AM EDT - 2 days ago

aTyr Pharma Proxy statement: Proxy filing


aTyr Pharma Proxy statement: Proxy filing

Aug 31, 2026, 8:00 AM EDT - 13 days ago

aTyr Pharma Proxy statement: Proxy filing


aTyr Pharma reports Q2 EPS (11c), consensus (13c)

2026-08-07T20:10:20.000Z - 5 weeks ago

aTyr Pharma reports Q2 EPS (11c), consensus (13c)


aTyr Pharma Quarterly report: Q2 2026

Aug 7, 2026, 7:00 AM EDT - 5 weeks ago

aTyr Pharma Quarterly report: Q2 2026


aTyr Pharma Earnings release: Q2 2026

Aug 7, 2026, 7:00 AM EDT - 5 weeks ago

aTyr Pharma Earnings release: Q2 2026


aTyr Pharma Transcript: Life Sciences Virtual Investor Forum

Jun 25, 2026, 3:30 PM EDT - 2 months ago

aTyr Pharma Transcript: Life Sciences Virtual Investor Forum


aTyr Pharma upgraded to Buy from Hold at Freedom Broker

2026-05-20T13:00:12.000Z - 3 months ago

aTyr Pharma upgraded to Buy from Hold at Freedom Broker


Ethos to Present at Upcoming Investor Conferences

May 15, 2026, 4:30 PM EDT - 4 months ago

Ethos to Present at Upcoming Investor Conferences

LIFE


aTyr Pharma reports Q1 EPS (11c), consensus (15c)

2026-05-15T15:42:31.000Z - 4 months ago

aTyr Pharma reports Q1 EPS (11c), consensus (15c)


aTyr Pharma Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 4 months ago

aTyr Pharma Quarterly report: Q1 2026


aTyr Pharma Earnings release: Q1 2026

May 15, 2026, 7:00 AM EDT - 4 months ago

aTyr Pharma Earnings release: Q1 2026


Ethos Announces Early Lock-Up Release

May 13, 2026, 4:35 PM EDT - 4 months ago

Ethos Announces Early Lock-Up Release

LIFE


aTyr Pharma to Participate in Upcoming Investor Conferences

May 13, 2026, 4:01 PM EDT - 4 months ago

aTyr Pharma to Participate in Upcoming Investor Conferences


aTyr Pharma Transcript: Study update

May 11, 2026, 4:30 PM EDT - 4 months ago

aTyr Pharma Transcript: Study update


aTyr Pharma Press release: Study update

May 11, 2026, 4:30 PM EDT - 4 months ago

aTyr Pharma Press release: Study update


aTyr Pharma Slides: Study update

May 11, 2026, 4:30 PM EDT - 4 months ago

aTyr Pharma Slides: Study update


aTyr Pharma Proxy statement: Proxy filing

Mar 26, 2026, 8:00 AM EDT - 5 months ago

aTyr Pharma Proxy statement: Proxy filing


aTyr Pharma Proxy statement: Proxy filing

Mar 26, 2026, 8:00 AM EDT - 5 months ago

aTyr Pharma Proxy statement: Proxy filing


aTyr Pharma Proxy statement: Proxy Filing

Mar 12, 2026, 8:00 AM EDT - 6 months ago

aTyr Pharma Proxy statement: Proxy Filing


aTyr Pharma reports Q4 EPS (14c), consensus (17c)

2026-03-05T21:05:56.000Z - 6 months ago

aTyr Pharma reports Q4 EPS (14c), consensus (17c)


aTyr Pharma Annual report: Q4 2025

Mar 5, 2026, 3:00 PM EST - 6 months ago

aTyr Pharma Annual report: Q4 2025


aTyr Pharma Earnings release: Q4 2025

Mar 5, 2026, 3:00 PM EST - 6 months ago

aTyr Pharma Earnings release: Q4 2025


Ethos to Participate in The Citizens Technology Conference

Feb 26, 2026, 4:06 PM EST - 6 months ago

Ethos to Participate in The Citizens Technology Conference

LIFE


Ethos Announces Pricing of Initial Public Offering

Jan 28, 2026, 10:38 PM EST - 7 months ago

Ethos Announces Pricing of Initial Public Offering


aTyr Pharma reports Q3 EPS (26c), consensus (18c)

2025-11-06T21:26:32.000Z - 10 months ago

aTyr Pharma reports Q3 EPS (26c), consensus (18c)


aTyr Pharma Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 10 months ago

aTyr Pharma Earnings release: Q3 2025


aTyr Pharma Quarterly report: Q3 2025

Nov 6, 2025, 4:00 PM EST - 10 months ago

aTyr Pharma Quarterly report: Q3 2025


akshgaikwad
akshgaikwad Sep. 11 at 9:11 PM
$ATYR dont they have to reverse split?? Stock is below $1.X for long time
0 · Reply
saneguy
saneguy Sep. 11 at 2:51 PM
$ATYR slow death march to the 30s before October’s stock split
0 · Reply
tedypa
tedypa Sep. 10 at 5:30 AM
0 · Reply
J__KARDOSS
J__KARDOSS Sep. 10 at 5:26 AM
0 · Reply
J__KARDOSS
J__KARDOSS Sep. 10 at 5:21 AM
0 · Reply
SpartanTrader117
SpartanTrader117 Sep. 10 at 12:20 AM
$ATYR easy short play
0 · Reply
MollyJones567
MollyJones567 Sep. 6 at 9:19 PM
$ATYR watching how the pipeline updates translate into the next earnings print. Market's been choppy but the focus stays on data readouts and cash runway commentary. Curious if guidance shifts at all this round. No rush, just observing how the story develops.
1 · Reply
Merlintrader
Merlintrader Sep. 2 at 10:22 AM
aTyr Pharma ($ATYR) Stock Hub 2026: What Does The FDA Protocol Response Change For The Efzofitimod Rebuild? https://www.merlintrader.com/atyr-pharma-stock-hub/
0 · Reply
STACKD0E
STACKD0E Sep. 1 at 10:44 PM
$ATYR $TLX 👁
0 · Reply
focafoca99
focafoca99 Sep. 1 at 9:05 PM
$ATYR provided an update on the expected FDA response timing for its Phase 3 efzofitimod pulmonary sarcoidosis study, now due mid-Sept 2026.
2 · Reply
Indialli1309
Indialli1309 Sep. 1 at 8:43 PM
$ATYR https://investors.atyrpharma.com/news-releases/news-release-details/atyr-pharma-provides-update-timing-regulatory-response-planned
0 · Reply
Houzehero
Houzehero Sep. 1 at 6:43 PM
$ATYR A reverse split is actually bullish If you believe that the newly designed Phase 3 Efzo-Fit trial will succeed. A 10 for 1 split reduces the share count to around 10m, add dilution thru the ATM to fund the trial, say another 10m shares = 20m share count. Phase 3 win for Efzo-fit with a $5B TAM and a Phase 2 Connect win preceding this would more than likely lead to a swift M&A negotiated by Dalia.R.Rayes. A $2 Billion typical buyout on a 20 million consolidated share count translates to $100.00 per share.
2 · Reply
Houzehero
Houzehero Sep. 1 at 6:33 PM
$ATYR A reverse split is actually bullish If you believe that the newly designed Phase 3 Efzo-Fit trial will succeed. 10 for 1 split reduces the share count to around 10m, add dilution thru the ATM to fund the trial, say another 10m shares = 20m share count. Phase 3 win for Efzo-fit with a $5B TAM and a Phase 2 Connect win preceding this would more than likely lead to a swift M&A negotiated by Dalia.R.Rayes. A $2 Billion typical buyout on a 20 million share count translates to $100.00 per share.
1 · Reply
__Godzilla__
__Godzilla__ Aug. 31 at 2:00 PM
$ATYR Where are all of the idiots who were so sure that a reverse split wasn't going to be needed? Reverse split and dilution has been inevitable since the testing failure.
0 · Reply
HansDampf1
HansDampf1 Aug. 31 at 1:12 PM
$ATYR " a Special Meeting of Stockholders (including any adjournments, continuations or postponements thereof, the “Special Meeting”) of aTyr Pharma, Inc., a Delaware corporation (the “Company,” “we,” “our” or “us”). The Special Meeting will be held on October 16, 2026 at 9:00 a.m. Pacific Time at the Company’s corporate headquarters..." "--To approve a series of alternate amendments to our restated certificate of incorporation to effect, at the option of our Board of Directors, a reverse stock split of our common stock at a ratio between 1-for-10 and 1-for-50, inclusive, as determined by our Board of Directors in its sole discretion; "https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=320318363&type=HTML&symbol=ATYR&cdn=1bc7cda96663bb6b8167db21c97b83d6&companyName=aTyr+Pharma+Inc.&formType=PRE+14A&formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&dateFiled=2026-08-31
1 · Reply
SpartanTrader117
SpartanTrader117 Aug. 31 at 1:10 PM
$ATYR reverse split coming
0 · Reply
stefano62
stefano62 Aug. 31 at 12:50 PM
$ATYR it seems that also today there is no news about fda new protocl acceptance....Hopefully it will drop later this week
0 · Reply
Spiceman63
Spiceman63 Aug. 31 at 11:57 AM
$ATYR Looks like a special meeting in September for a reverse split vote. I just sold a little.
2 · Reply
Wallace911
Wallace911 Aug. 31 at 11:30 AM
$ATYR New Form PRE 14A for aTyr Pharma (Nouveau formulaire PRE 14A pour aTyr Pharma)
1 · Reply
FrostyOrbit
FrostyOrbit Aug. 29 at 7:19 PM
$ATYR $58.9M cash/investments at June 30, 2026 with runway projected into late 2028 under current plans..,
1 · Reply
stefano62
stefano62 Aug. 28 at 10:15 AM
$ATYR beeing today Friday tò me It Is very unorobable tò have the issue of the PR About FDA reaction today, even if they received It. We Will see next eeek
0 · Reply
Indialli1309
Indialli1309 Aug. 27 at 7:17 AM
$ATYR https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-atyr/atyr-pharma/news/atyr-pharma-and-2-other-penny-stocks-with-promising-potentia
0 · Reply